Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
Status:
Unknown status
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This is a two-part, open-label, Phase I/II study in subjects with relapsed or refractory
TdT-positive leukemia for which no standard therapies are expected to result in durable
remission.